Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	165.65	131.54	123.65	141.52	203.52	139.68
Short-Term Investments	-	138.37	199.46	202.75	296.33	262.43
Cash & Short-Term Investments	165.65	269.91	323.11	344.27	499.85	402.11
Cash Growth	-37.51%	-16.46%	-6.15%	-31.12%	24.31%	-12.04%
Accounts Receivable	8.13	16.27	10.19	5.15	0.27	6.05
Receivables	8.13	16.27	10.19	5.15	0.27	6.05
Prepaid Expenses	3.11	3.14	7.53	7.34	7.2	10.93
Total Current Assets	176.89	289.32	340.83	356.75	507.31	419.09
Property, Plant & Equipment	21.87	47.05	45.71	59.22	43.29	39.15
Long-Term Investments	-	-	104.02	93.1	120.07	109.66
Other Long-Term Assets	2.99	5.22	8.59	5.25	6.81	4.7
Total Assets	201.75	341.59	499.15	514.32	677.48	572.6
Accounts Payable	3.16	5.49	8.27	9.51	5.05	6.41
Accrued Expenses	18.44	44.1	34.56	31.3	20.19	24.05
Current Portion of Leases	6.09	14.65	12.16	11.08	10.31	6.81
Current Unearned Revenue	5	11.22	8.22	8.22	11.33	20.94
Other Current Liabilities	29.08	1.76	-	-	-	-
Total Current Liabilities	61.77	77.23	63.22	60.11	46.88	58.21
Long-Term Leases	13.56	20.38	24.37	32.86	16.07	19.32
Long-Term Unearned Revenue	108.27	106.64	60.67	60.67	60.89	73.98
Other Long-Term Liabilities	4.69	3.07	1.8	-	-	27.5
Total Liabilities	188.3	207.32	150.06	153.64	123.84	179.02
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,636	1,602	1,580	1,442	1,412	1,059
Retained Earnings	-1,623	-1,468	-1,231	-1,078	-857.7	-665.2
Comprehensive Income & Other	-	0.27	0.2	-3.6	-0.49	-0.05
Total Common Equity	13.45	134.27	349.1	360.68	553.64	393.59
Shareholders' Equity	13.45	134.27	349.1	360.68	553.64	393.59
Total Liabilities & Equity	201.75	341.59	499.15	514.32	677.48	572.6
Total Debt	19.65	35.03	36.54	43.95	26.38	26.14
Net Cash (Debt)	146	234.88	390.6	393.43	593.54	485.64
Net Cash Growth	-35.57%	-39.87%	-0.72%	-33.72%	22.22%	13.45%
Net Cash Per Share	1.72	2.85	5.14	5.73	8.78	8.29
Filing Date Shares Outstanding	97.62	82.98	81.81	67.47	68.46	67.24
Total Common Shares Outstanding	93.26	82.73	81.77	67.35	68.44	62.56
Working Capital	115.12	212.09	277.61	296.64	460.43	360.88
Book Value Per Share	0.14	1.62	4.27	5.36	8.09	6.29
Tangible Book Value	13.45	134.27	349.1	360.68	553.64	393.59
Tangible Book Value Per Share	0.14	1.62	4.27	5.36	8.09	6.29
Machinery	23.01	30.88	26.37	25.55	22.72	19.17
Construction In Progress	0.08	0.83	2.06	1.57	1.53	0.86
Leasehold Improvements	8.4	11.75	9.65	9.76	8.16	4.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.